Fig. 2

Putative RIP based conjugates. a ImmunoRIPs obtained fusing RIPs to antibody (left) or minibody, as scFv (right). b Alternative bioconiujates obtained fusing RIPs to receptors (left), cellular ligands (center) and protease inhibitors (right)
Putative RIP based conjugates. a ImmunoRIPs obtained fusing RIPs to antibody (left) or minibody, as scFv (right). b Alternative bioconiujates obtained fusing RIPs to receptors (left), cellular ligands (center) and protease inhibitors (right)